QUOTE AND NEWS
Wall Street Journal  7 hrs ago  Comment 
Eli Lilly said it would extend a Phase 3 trial of its investigational treatment for high-risk cases of atherosclerotic cardiovascular disease.
Jutia Group  Feb 11  Comment 
[PR Newswire] - The stress of freshman year can be multiplied when the student is managing a chronic disease such as type 1 diabetes. To help ease the burden, Lilly Diabetes today announced the fulfillment of its two-year, $200,000 commitment...
Wall Street Journal  Feb 5  Comment 
A federal judge sentenced Yosmany Nunez to six years and three months in prison for his role in the 2010 heist of an estimated $80 million worth of prescription drugs from an Eli Lilly warehouse in Connecticut.
FiercePharma  Feb 4  Comment 
After a year of regulatory warnings and safety debates over "Low T" drugs, it's no surprise that drugmakers like Eli Lilly and AbbVie expect their testosterone sales to suffer in 2015. But as the mainstream medical community apparently moves...
Market Intelligence Center  Feb 4  Comment 
Eli Lilly and Co (LLY) closed Tuesday at $70.89 and technical indicators recently have been bullish. Based in part on those numbers, MarketIntelligenceCenter.com's patented algorithms have identified a couple of attractive trading opportunities in...
Jutia Group  Feb 3  Comment 
[PR Newswire] - Diabetes camping can change lives for kids with #T1D. Today Lilly Diabetes announced its support of the American Diabetes Association (Association) summer camp program by donating $92,000 for camp scholarships – $1,000 for each...
FierceBiotech  Feb 2  Comment 
Partners Eli Lilly and Boehringer Ingelheim picked up FDA approval for a first-of-its-kind diabetes treatment, combining two existing drugs into a single tablet.
Benzinga  Feb 2  Comment 
UBS on Monday issued a report on Eli Lilly and Co (NYSE: LLY). The firm rates Eli Lilly as Neutral with a one-year price target of $69.00. Analyst Marc Goodman wrote , “Management has done a nice job getting through the difficult patent...
Jutia Group  Feb 2  Comment 
[Reuters] - The U.S. Food and Drug Administration approved a drug developed by Eli Lilly and Co and privately held Boehringer Ingelheim Pharmaceuticals Inc to improve blood sugar control in type-2 diabetes patients, ... Read more on this. Eli...




 

Very nice site!

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki